{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:08:33Z","timestamp":1761293313235},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1605-2","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T11:05:26Z","timestamp":1440673526000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Incomplete Dll4\/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas"],"prefix":"10.1186","volume":"15","author":[{"given":"Dusan","family":"Djokovic","sequence":"first","affiliation":[]},{"given":"Alexandre","family":"Trindade","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Gigante","sequence":"additional","affiliation":[]},{"given":"Mario","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Duarte","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"1605_CR1","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1101\/gad.1239004","volume":"18","author":"A Duarte","year":"2004","unstructured":"Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004;18:2474\u20138.","journal-title":"Genes Dev"},{"key":"1605_CR2","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1101\/gad.1239204","volume":"18","author":"LT Krebs","year":"2004","unstructured":"Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004;18:2469\u201373.","journal-title":"Genes Dev"},{"key":"1605_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.modgep.2004.05.004","volume":"5","author":"S Claxton","year":"2004","unstructured":"Claxton S, Fruttiger M. Periodic Delta-like 4 expression in developing retinal arteries. Gene Expr Patterns. 2004;5:123\u20137.","journal-title":"Gene Expr Patterns"},{"key":"1605_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature05571","volume":"445","author":"M Hellstr\u00f6m","year":"2007","unstructured":"Hellstr\u00f6m M, Phng L-K, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature. 2007;445:776\u201380.","journal-title":"Nature"},{"key":"1605_CR5","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1073\/pnas.0611206104","volume":"104","author":"IB Lobov","year":"2007","unstructured":"Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A. 2007;104:3219\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1605_CR6","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1073\/pnas.0611177104","volume":"104","author":"S Suchting","year":"2007","unstructured":"Suchting S, Freitas C, Le Noble F, Benedito R, Br\u00e9ant C, Duarte A, et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A. 2007;104:3225\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1605_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029863","volume":"7","author":"A Trindade","year":"2012","unstructured":"Trindade A, Djokovic D, Gigante J, Badenes M, Pedrosa A-R, Fernandes A-C, et al. Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis. PLoS One. 2012;7, e29863.","journal-title":"PLoS One"},{"key":"1605_CR8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature05355","volume":"444","author":"I Noguera-Troise","year":"2006","unstructured":"Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006;444:1032\u20137.","journal-title":"Nature"},{"key":"1605_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nature05313","volume":"444","author":"J Ridgway","year":"2006","unstructured":"Ridgway J, Zhang G, Wu Y, Stawicki S, Liang W-C, Chanthery Y, et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006;444:1083\u20137.","journal-title":"Nature"},{"key":"1605_CR10","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1158\/0008-5472.CAN-07-0969","volume":"67","author":"J-L Li","year":"2007","unstructured":"Li J-L, Sainson RCA, Shi W, Leek R, Harrington LS, Preusser M, et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res. 2007;67:11244\u201353.","journal-title":"Cancer Res"},{"key":"1605_CR11","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1182\/blood-2006-12-063933","volume":"109","author":"JS Scehnet","year":"2007","unstructured":"Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, et al. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007;109:4753\u201360.","journal-title":"Blood"},{"key":"1605_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1186\/1471-2407-10-641","volume":"10","author":"D Djokovic","year":"2010","unstructured":"Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, et al. Combination of Dll4\/Notch and Ephrin-B2\/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer. 2010;10:641.","journal-title":"BMC Cancer"},{"key":"1605_CR13","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1038\/onc.2010.176","volume":"29","author":"BK Haller","year":"2010","unstructured":"Haller BK, Br\u00e5ve A, Wallgard E, Roswall P, Sunkari VG, Mattson U, et al. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma. Oncogene. 2010;29:4276\u201386.","journal-title":"Oncogene"},{"key":"1605_CR14","first-page":"2143","volume":"7","author":"G-H Hu","year":"2014","unstructured":"Hu G-H, Liu H, Lai P, Guo Z-F, Xu L, Yao X-D, et al. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo. Int J Clin Exp Pathol. 2014;7:2143\u201352.","journal-title":"Int J Clin Exp Pathol"},{"key":"1605_CR15","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2353\/ajpath.2010.090908","volume":"176","author":"AM Jubb","year":"2010","unstructured":"Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, et al. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010;176:2019\u201328.","journal-title":"Am J Pathol"},{"issue":"Suppl 3","key":"1605_CR16","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1245\/s10434-011-1968-9","volume":"19","author":"H-T Chen","year":"2012","unstructured":"Chen H-T, Cai Q-C, Zheng J-M, Man X-H, Jiang H, Song B, et al. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Ann Surg Oncol. 2012;19 Suppl 3:S464\u201374.","journal-title":"Ann Surg Oncol"},{"key":"1605_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12032-012-0390-x","volume":"30","author":"J-X Zhang","year":"2013","unstructured":"Zhang J-X, Cai M-B, Wang X-P, Duan L-P, Shao Q, Tong Z-T, et al. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma. Med Oncol. 2013;30:390.","journal-title":"Med Oncol"},{"key":"1605_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018709","volume":"6","author":"M Kal\u00e9n","year":"2011","unstructured":"Kal\u00e9n M, Heikura T, Karvinen H, Nitzsche A, Weber H, Esser N, et al. Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion. PLoS One. 2011;6, e18709.","journal-title":"PLoS One"},{"key":"1605_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.stem.2009.05.019","volume":"5","author":"T Hoey","year":"2009","unstructured":"Hoey T, Yen W-C, Axelrod F, Basi J, Donigian L, Dylla S, et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell. 2009;5:168\u201377.","journal-title":"Cell Stem Cell"},{"key":"1605_CR20","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1038\/nature08751","volume":"463","author":"M Yan","year":"2010","unstructured":"Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, et al. Chronic DLL4 blockade induces vascular neoplasms. Nature. 2010;463:E6\u20137.","journal-title":"Nature"},{"key":"1605_CR21","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2217\/fon.10.62","volume":"6","author":"J-L Li","year":"2010","unstructured":"Li J-L, Jubb AM, Harris AL. Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity. Future Oncol. 2010;6:1099\u2013103.","journal-title":"Future Oncol"},{"key":"1605_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccr.2009.05.016","volume":"16","author":"S Demehri","year":"2009","unstructured":"Demehri S, Turkoz A, Kopan R. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell. 2009;16:55\u201366.","journal-title":"Cancer Cell"},{"key":"1605_CR23","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/cncr.20680","volume":"101","author":"M Gill","year":"2004","unstructured":"Gill M, Cohen J, Renwick N, Mones JM, Silvers DN, Celebi JT. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Cancer. 2004;101:2636\u201340.","journal-title":"Cancer"},{"key":"1605_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2133.2011.10744.x","volume":"166","author":"DH Siegel","year":"2012","unstructured":"Siegel DH, Mann JA, Krol AL, Rauen KA. Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development. Br J Dermatol. 2012;166:601\u20137.","journal-title":"Br J Dermatol"},{"key":"1605_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood-2005-03-1000","volume":"107","author":"CK Williams","year":"2006","unstructured":"Williams CK, Li J-L, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood. 2006;107:931\u20139.","journal-title":"Blood"},{"key":"1605_CR26","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2007-09-112748","volume":"112","author":"A Trindade","year":"2008","unstructured":"Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, et al. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood. 2008;112:1720\u20139.","journal-title":"Blood"},{"key":"1605_CR27","first-page":"5391","volume":"56","author":"F Larcher","year":"1996","unstructured":"Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, et al. Up-regulation of vascular endothelial growth factor\/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 1996;56:5391\u20136.","journal-title":"Cancer Res"},{"key":"1605_CR28","doi-asserted-by":"publisher","first-page":"11205","DOI":"10.1073\/pnas.172161899","volume":"99","author":"IB Lobov","year":"2002","unstructured":"Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002;99:11205\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1605_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70\u20134.","journal-title":"Nature"},{"key":"1605_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1210\/rp.59.1.51","volume":"59","author":"KG Peters","year":"2004","unstructured":"Peters KG, Kontos CD, Lin PC, Wong AL, Rao P, Huang L, et al. Functional significance of Tie2 signaling in the adult vasculature. Recent Prog Horm Res. 2004;59:51\u201371.","journal-title":"Recent Prog Horm Res"},{"key":"1605_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2005.10.034","volume":"124","author":"SS Foo","year":"2006","unstructured":"Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N, et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell. 2006;124:161\u201373.","journal-title":"Cell"},{"key":"1605_CR32","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358:2039\u201349.","journal-title":"N Engl J Med"},{"key":"1605_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0076-6879(05)07047-3","volume":"407","author":"L Adnane","year":"2006","unstructured":"Adnane L, Trail PA, Taylor I, Wilhelm SM. Sorafenib (BAY 43\u20139006, Nexavar), a dual-action inhibitor that targets RAF\/MEK\/ERK pathway in tumor cells and tyrosine kinases VEGFR\/PDGFR in tumor vasculature. Meth Enzymol. 2006;407:597\u2013612.","journal-title":"Meth Enzymol"},{"key":"1605_CR34","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature08995","volume":"465","author":"S Sawamiphak","year":"2010","unstructured":"Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, et al. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature. 2010;465:487\u201391.","journal-title":"Nature"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1605-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1605-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T21:04:53Z","timestamp":1475787893000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1605-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1605"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1605-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]},"article-number":"608"}}